AmerisourceBergen Corp. (ABC)

91.80
0.23 0.25
NYSE : Distribution Services
Prev Close 91.57
Open 90.83
Day Low/High 90.39 / 92.06
52 Wk Low/High 71.90 / 106.27
Volume 349.96K
Avg Volume 1.53M
Exchange NYSE
Shares Outstanding 219.80M
Market Cap 20.85B
EPS 1.70
P/E Ratio 24.57
Div & Yield 1.52 (1.61%)
Play the Dip on AmerisourceBergen

Play the Dip on AmerisourceBergen

A low risk stock with a moderate upside makes sense.

Healthcare Stocks Rebound After President Trump's Speech on Drug Pricing

Healthcare Stocks Rebound After President Trump's Speech on Drug Pricing

President Trump delivered a highly-anticipated speech on lowering the cost of drugs for Americans on Friday afternoon.

What to Expect From Trump's Speech on Drug Prices on Friday

What to Expect From Trump's Speech on Drug Prices on Friday

Since taking office, President Trump has talked big on reining in drug prices, but the administration's lack of action leaves most expecting a May 11 speech that tastes like a nothing burger.

AmerisourceBergen Declares Quarterly Dividend

AmerisourceBergen Declares Quarterly Dividend

The Board of Directors of AmerisourceBergen Corporation (NYSE: ABC) today declared a quarterly dividend of $0.

Congressional Committee Grills Drug Distributors on Opioid Crisis Roles

Congressional Committee Grills Drug Distributors on Opioid Crisis Roles

One drug distribution executive appearing before a House Committee to answer for shipping millions of doses of opioids into West Virginia apologized and another said his company had a hand in the crisis.

Cardinal Health Plunges After Negative Earnings Revision

Cardinal Health Plunges After Negative Earnings Revision

Cardinal Health had its worst day of trading in 14 years.

AmerisourceBergen Reports Fiscal 2018 Second Quarter Results

AmerisourceBergen Reports Fiscal 2018 Second Quarter Results

AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2018 second quarter ended March 31, 2018, revenue increased 10.

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

An internal review of management behavior at the healthcare company over opioid distribution prompted by complaints from shareholder International Brotherhood of Teamsters gives company officials a clean bill of health.

Congress Sets Opioid Hearing Next Month for Drug Distributors

Congress Sets Opioid Hearing Next Month for Drug Distributors

A House committee trying to understand how the opioid crisis came to be and what to do next has set a May 8 hearing for drug distributors to explain their role.

American Medical Association Rejects Idea of Time Limits on Opioid Scripts

American Medical Association Rejects Idea of Time Limits on Opioid Scripts

While more than half the states in the U.S. have passed time limits on opioid prescription as a way to battle the epidemic, the AMA says that should be left up to the doctor and patient.

McKesson Lawsuit Puts Drug Distributors Back Into Harsh Public Spotlight

McKesson Lawsuit Puts Drug Distributors Back Into Harsh Public Spotlight

McKesson and other drug distributors are having a difficult time steering clear of controversy, with the latest blow a lawsuit alleging McKesson has violated the False Claims Act.

Walmart and Target Look Like They Are Freaking Out Because of Amazon

Walmart and Target Look Like They Are Freaking Out Because of Amazon

The rumors are coming in hot and heavy on possible moves Walmart and Target are making to keep at Amazon at bay. Meanwhile, stocks just closed below this key point. Rejoice, bears.

Should Walgreens Forget About a Healthcare Deal?

Should Walgreens Forget About a Healthcare Deal?

One analyst cited 'the stability of retail' as a safe harbor for Walgreens.

Trump Opioid Policy Rollout Includes Call for Death Penalty for Dealers

Trump Opioid Policy Rollout Includes Call for Death Penalty for Dealers

President Trump made a long-awaited announcement of his administration's opioid plan in a New Hampshire speech that was part policy roll out and part political rally.

AmerisourceBergen To Participate In Barclays Global Healthcare Conference

AmerisourceBergen To Participate In Barclays Global Healthcare Conference

AmerisourceBergen Corporation (NYSE: ABC) today announced that it will present at the Barclays Global Healthcare Conference at 2:05 p.

Healthcare Stocks Trade Mixed on Cigna's Massive $67 Billion Express Scripts Bid

Healthcare Stocks Trade Mixed on Cigna's Massive $67 Billion Express Scripts Bid

As further consolidation in the industry comes back into focus, stocks are teetering.

Why Amazon Should Freak Out Cigna Is Spending $67 Billion on Express Scripts

Why Amazon Should Freak Out Cigna Is Spending $67 Billion on Express Scripts

Amazon must move soon to acquire a key healthcare franchise before it misses out completely on rich opportunities or pays too much. Goldman Sachs is scared about markets in 2019.

Study: Over-the-Counter Meds More Effective For Chronic Back Pain Than Opioids

Study: Over-the-Counter Meds More Effective For Chronic Back Pain Than Opioids

A study published by the Journal of the American Medical Association shows OTC drugs were more effective in cutting pain for chronic back pain and osteoarthritis hip and knee patients than opioids.

The Price Action In AmerisourceBergen Has Been Disappointing Lately

The Price Action In AmerisourceBergen Has Been Disappointing Lately

A fresh look at the charts and indicators of ABC seems timely.

Short Interest Decreases By 35% For ABC

Short Interest Decreases By 35% For ABC

The most recent short interest data has been released for the 02/15/2018 settlement date, which shows a 2,644,531 share decrease in total short interest for AmerisourceBergen Corp. , to 4,897,883, a decrease of 35.06% since 01/31/2018.

Attorney General Sessions Announces New Federal Opioids Taskforce

Attorney General Sessions Announces New Federal Opioids Taskforce

After months of inaction by the federal government on the crisis regarding opioid abuse, Attorney General Jeff Sessions announced the creation of a task force charged with looking at how drug makers and distributors operate.

Why a Walgreens Purchase of Humana or WellCare Now Appears Less Likely

Why a Walgreens Purchase of Humana or WellCare Now Appears Less Likely

Walgreens and AmerisourceBergen are talking about a deal.

Dow, S&P 500 and Nasdaq Finish Higher, Posting Third Consecutive Day of Gains

Dow, S&P 500 and Nasdaq Finish Higher, Posting Third Consecutive Day of Gains

Stocks ended higher on Tuesday.

Does Walgreens Buying AmerisourceBergen Make Any Sense?

Does Walgreens Buying AmerisourceBergen Make Any Sense?

Should Walgreens really buy the rest of AmerisourceBergen that it doesn't already own? Analysts seem conflicted.

Watch: Jim Cramer Reacts to a Potential Walgreens AmerisourceBergen Deal

Watch: Jim Cramer Reacts to a Potential Walgreens AmerisourceBergen Deal

The Wall Street Journal reported that Walgreens Boots Alliance has contacted AmerisourceBergen about a possible takeover.

Dow Futures Are Plunging Again

Dow Futures Are Plunging Again

Wall Street futures were down Tuesday as the dollar saw modest losses against most major currencies.

Amazon, AmerisourceBergen and Everything Else You Need to Know Before You Trade

Amazon, AmerisourceBergen and Everything Else You Need to Know Before You Trade

With Dow futures pointed south, it looks to be another interesting day on Wall Street. Here's what you need to know.

Walgreens, AmerisourceBergen, Amazon and GM - 5 Things You Must Know

Walgreens, AmerisourceBergen, Amazon and GM - 5 Things You Must Know

U.S. stock futures are under pressure on Tuesday, following strong gains on Monday that saw the Dow Jones Industrial Average rise more than 400 points.

AmerisourceBergen Shares Jump After-Hours on Walgreens Bid Report

AmerisourceBergen Shares Jump After-Hours on Walgreens Bid Report

Walgreens approached Amerisource last week, according to a published report.

Purdue Pharma to Downplay Opioids, Dump 50% of Sales Staff

Purdue Pharma to Downplay Opioids, Dump 50% of Sales Staff

As lawsuits tied to the opioid crisis keep piling up, Purdue Pharma is discontinuing direct sales calls to doctors. Will other opioid makers follow suit?

TheStreet Quant Rating: B- (Buy)